CA2905404C - Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar - Google Patents

Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar Download PDF

Info

Publication number
CA2905404C
CA2905404C CA2905404A CA2905404A CA2905404C CA 2905404 C CA2905404 C CA 2905404C CA 2905404 A CA2905404 A CA 2905404A CA 2905404 A CA2905404 A CA 2905404A CA 2905404 C CA2905404 C CA 2905404C
Authority
CA
Canada
Prior art keywords
composition
paag
polyglucosamine
amount
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2905404A
Other languages
English (en)
French (fr)
Other versions
CA2905404A1 (en
Inventor
Stacy M. Townsend
Shenda Baker
William P. Wiesmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synedgen Inc
Original Assignee
Synedgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synedgen Inc filed Critical Synedgen Inc
Publication of CA2905404A1 publication Critical patent/CA2905404A1/en
Application granted granted Critical
Publication of CA2905404C publication Critical patent/CA2905404C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C17/00—Devices for cleaning, polishing, rinsing or drying teeth, teeth cavities or prostheses; Saliva removers; Dental appliances for receiving spittle
    • A61C17/16—Power-driven cleaning or polishing devices
    • A61C17/20—Power-driven cleaning or polishing devices using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2905404A 2013-03-12 2014-03-12 Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar Active CA2905404C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361778077P 2013-03-12 2013-03-12
US61/778,077 2013-03-12
PCT/US2014/024864 WO2014165226A2 (en) 2013-03-12 2014-03-12 Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar

Publications (2)

Publication Number Publication Date
CA2905404A1 CA2905404A1 (en) 2014-10-09
CA2905404C true CA2905404C (en) 2021-07-20

Family

ID=51659323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2905404A Active CA2905404C (en) 2013-03-12 2014-03-12 Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar

Country Status (6)

Country Link
US (2) US20160022564A1 (enExample)
EP (1) EP2968080B1 (enExample)
JP (2) JP6842916B2 (enExample)
AU (2) AU2014248562B2 (enExample)
CA (1) CA2905404C (enExample)
WO (1) WO2014165226A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
EP3311823B1 (en) 2009-09-02 2020-11-25 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
EP2555760B1 (en) 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
CA2883704C (en) 2012-09-20 2021-09-28 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
WO2014165226A2 (en) 2013-03-12 2014-10-09 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
EP3190886B1 (en) 2014-09-11 2024-04-10 Synedgen, Inc. Compositions for use in the treatment of acute respiratory distress syndrome
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
GB201701404D0 (en) 2017-01-27 2017-03-15 Micropharm Ltd Therapies for treating inflammatory disorders
CN107334782A (zh) * 2017-07-26 2017-11-10 吉林省始祖生物波医学研究院有限公司 一种抑菌消炎剂及其制备方法和应用
EP3727336A1 (en) 2017-12-20 2020-10-28 3M Innovative Properties Company Oral compositions and methods of use
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
GB201812261D0 (en) * 2018-07-27 2018-09-12 Micropharm Ltd Therapies for treating oral mucositis
US12083209B2 (en) 2020-02-18 2024-09-10 Sunstar Americas, Inc. Oral care composition

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229430A (en) 1978-08-21 1980-10-21 Fahim Mostafa S Oral composition for improving oral health
US4512968A (en) * 1982-11-30 1985-04-23 Lion Corporation Oral compositions
US4839156A (en) * 1987-04-17 1989-06-13 Colgate-Palmolive Company Stable hydrogen peroxide dental gel
NL9301837A (nl) * 1993-10-22 1995-05-16 Sara Lee De Nv Mondverzorgingsmiddel.
US5541165A (en) * 1994-09-27 1996-07-30 Turgeon; Jean A. Saliva substitute
AU2001271545A1 (en) 2000-06-30 2002-01-14 The Procter And Gamble Company Promoting whole body health
US6723305B2 (en) 2002-03-04 2004-04-20 Colgate Palmolive Company Anti-microbial breath freshening mouthrinse
CA2504283A1 (en) * 2002-10-31 2004-05-21 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia
US20040103821A1 (en) * 2002-11-29 2004-06-03 Freund Industrial Co., Ltd. Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
WO2005119227A1 (ja) 2004-06-04 2005-12-15 Tokyo Seimitsu Co., Ltd. 半導体外観検査装置及び照明方法
WO2006005211A1 (de) 2004-07-12 2006-01-19 Gaba International Ag Mundpflegemittel enthaltend chitosanderivat
US8858920B2 (en) 2004-12-21 2014-10-14 Colgate-Palmolive Company Anti-caries oral care composition with xylitol
JP2007314505A (ja) 2006-04-28 2007-12-06 Nagasaki Univ 機能性チューインガム
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
US20080248508A1 (en) 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
WO2008063503A2 (en) 2006-11-13 2008-05-29 Hawaii Chitopure, Inc. Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials.
EP1955710A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Aqueous composition comprising chitosan and an acidic drug
WO2010021930A1 (en) * 2008-08-16 2010-02-25 Synedgen, Inc. Prevention and treatment of mrsa infections with chitosan-derivatives
US8399635B2 (en) 2008-11-12 2013-03-19 Synedgen, Inc. Chitosan derivatives to treat animals or optimize animal health
WO2010056927A1 (en) 2008-11-12 2010-05-20 Synedgen, Inc. Chitosan derivatives alone or in combination for the treatment of mdr microbial infections
WO2010081204A2 (en) * 2009-01-14 2010-07-22 Katholieke Universiteit Leuven Activators of the autophagic pathway
CA2751268A1 (en) 2009-01-29 2010-08-05 Synedgen, Inc. Nucleic acid delivery using modified chitosans
FR2941846B1 (fr) * 2009-02-10 2012-05-11 Dominique Valeri Adjuvant alimentaire comme agent reducteur de pouvoir cariogene de produits sucres
EP2473043B1 (en) 2009-09-02 2020-03-25 Synedgen, Inc. Oral care methods and compositions utilizing chitosan-derivative compounds
EP3311823B1 (en) 2009-09-02 2020-11-25 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
EP2555760B1 (en) * 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
CN102085371B (zh) * 2011-01-28 2013-03-13 武汉耦合医学科技有限责任公司 一种口腔干燥症含漱液医疗用品及其制备方法
US20140221308A1 (en) 2011-07-01 2014-08-07 Synedgen, Inc. Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds
WO2013134129A2 (en) 2012-03-05 2013-09-12 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
CA2883704C (en) 2012-09-20 2021-09-28 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
WO2014165226A2 (en) 2013-03-12 2014-10-09 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
JP2016519667A (ja) 2013-03-15 2016-07-07 シネジェン， インコーポレイテッド 創傷治癒のための組成物および使用方法

Also Published As

Publication number Publication date
JP6842916B2 (ja) 2021-03-17
WO2014165226A3 (en) 2014-12-31
AU2014248562A1 (en) 2015-10-01
JP2016512545A (ja) 2016-04-28
JP2019137702A (ja) 2019-08-22
US10765616B2 (en) 2020-09-08
WO2014165226A2 (en) 2014-10-09
US20180289609A1 (en) 2018-10-11
US20160022564A1 (en) 2016-01-28
EP2968080A2 (en) 2016-01-20
AU2014248562B2 (en) 2019-01-03
AU2019202092A1 (en) 2019-04-18
CA2905404A1 (en) 2014-10-09
EP2968080B1 (en) 2023-05-10
EP2968080A4 (en) 2016-08-31

Similar Documents

Publication Publication Date Title
US10765616B2 (en) Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
AU2017225141B2 (en) Oral Care Methods And Compositions Utilizing Chitosan-Derivative Compounds
Demir et al. Antimicrobial effect of natural kinds of toothpaste on oral pathogenic bacteria
AU2016381178B2 (en) Mucin coated silica for bacterial aggregation
WO2020141201A1 (en) Antibacterial oral compositions
CN107106451A (zh) 口腔护理组合物
JP2003246717A (ja) 口腔用組成物
Fang et al. Modified casein-stabilized amorphous calcium phosphate nanoparticles prevent dental caries by inhibiting the growth of Streptococcus mutans and promoting the remineralization of tooth enamel
RU2813879C1 (ru) Противовоспалительная композиция (варианты) для местного применения в полости рта и верхних дыхательных путях
JP3728513B2 (ja) キトサンオリゴ糖含有抗菌薬、齲蝕原性細菌の発育を抑制する方法
Reji A Comparative Evaluation Of The Antibacterial Efficacy Of Various R0ot Canal Irrigants Against E. Fecalis: An In-Vitro Study
CN118576531A (zh) 一种后生元组合物牙膏及其制备方法
CN114469761A (zh) 口腔护理组合物及其使用和制备方法
JP2004091413A (ja) キトサンオリゴ糖含有齲蝕予防・抑制剤

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190312